Nu-Med Plus (NUMD) Capital Expenditures (2012 - 2018)
Nu-Med Plus' (NUMD) quarterly Capital Expenditures came in at $1.0 in Q4 2018, up 100.09% quarter-over-quarter from -$1101.0 in Q4 2014.
Powered by 
Analysis
Nu-Med Plus (NUMD) Capital Expenditures (2012 - 2018) Analysis & Trends
Nu-Med Plus has disclosed Capital Expenditures across 4 years of filings, most recently posting $1.0 for Q4 2018.
- In Q4 2018, Capital Expenditures changed N/A year-over-year to $1.0; the TTM figure through Dec 2019 stood at $1.0 (changed 0.0% YoY), while the FY2018 annual figure was -$5025.0, changed N/A from the prior year.
- Capital Expenditures came in at $1.0 for Q4 2018 at Nu-Med Plus, up from -$1101.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.0 in Q4 2018 to a low of -$1101.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 1.00 |
| Dec 31, 2014 | -1,101.00 |
| Dec 31, 2013 | 27,240.00 |
| Sep 30, 2013 | 1,679.00 |
| Dec 31, 2012 | -36.00 |
| Sep 30, 2012 | 1.00 |
| Jun 30, 2012 | 18,835.00 |